Severe Aplastic Anemia Recovers With No Treatment — and the Immune System Explains How

The facts are about as solid as a single case allows. A 24-year-old woman in Japan was diagnosed with idiopathic severe aplastic anemia — a condition in which the immune system attacks the bone marrow until it can no longer make enough blood cells, usually demanding urgent immunosuppression or a stem-cell transplant. Instead, her blood counts began to improve on their own 11 days after diagnosis, with no treatment and no transfusions, and she remained in complete remission 30 months later, as of May 2025. The recovery is documented in a peer-reviewed report. The heart of this entry is that the recovery comes with a documented natural mechanism, and the authors are the ones who supply it. Genetic analysis of her blood found that 69% of her granulocytes had lost a specific HLA haplotype through acquired loss of heterozygosity, and 23% of her cells were glycosylphosphatidylinositol-deficient because of PIGA mutations. In plain terms: the immune attack in aplastic anemia is aimed at cells displaying particular surface markers, and her surviving stem cells had acquired changes that removed those markers — so they slipped past the attack and repopulated the marrow. Immune escape by HLA-loss and PIGA-mutant clones is a recognized route by which some patients recover without treatment. That is why the miracle meter stays low here. The recovery is real, durable, and rare — full, treatment-independent remission of severe aplastic anemia is uncommon — but it is not unexplained. The immunology accounts for it, and the molecular evidence for that account is unusually direct. The honest caution, as with every single case, is that one report shows a mechanism is possible, not that spontaneous remission is common or predictable; no one with this diagnosis should forgo treatment on the strength of it. Where this lands: strong evidence, and a natural explanation that largely closes the mechanism question rather than leaving it open.